IXHL — Incannex Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $35.71m
- $26.41m
- $0.93m
R2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
Revenue | |||||
Total Revenue | 0.001 | 0.551 | 1.47 | 0.572 | 0.926 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.96 | 3.18 | 9.95 | 11.4 | 14.4 |
Operating Profit | -0.959 | -2.63 | -8.48 | -10.8 | -13.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.02 | -2.63 | -8.48 | -10.8 | -13.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.02 | -2.63 | -8.48 | -10.8 | -13.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.94 | -3.15 | -8.48 | -10.8 | -13.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.94 | -3.15 | -8.48 | -10.8 | -13.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.002 | -0.004 | -0.009 | -0.009 | -0.009 |